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Mesenchymal stem cells are showing increasing promise in applications such as tissue engineering and cell therapy. MSC are low
in number in bone marrow, and therefore in vitro expansion is often necessary. In vivo, stem cells often reside within a niche acting
toprotect the cells. These niches are composed of niche cells, stem cells, and extracellular matrix. When blood vessels are damaged,
a ﬁbrin clot forms as part of the wound healing response. The clot constitutes a form of stem cell niche as it appears to maintain
the stem cell phenotype while supporting MSC proliferation and diﬀerentiation during healing. This is particularly appropriate
as ﬁbrin is increasingly being suggested as a scaﬀold meaning that ﬁbrin-based tissue engineering may to some extent recapitulate
wound healing. Here, we describe how ﬁbrin modulates the clonogenic capacity of MSC derived from young/old human donors
and normal/diabetic rats. Fibrin was prepared using diﬀerent concentrations to modulate the stiﬀness of the substrate. MSC were
expanded on these scaﬀolds and analysed. MSC showed an increased self-renewal on soft surfaces. Old and diabetic cells lost the
ability to react to these signals and can no longer adapt to the changed environment.
1.Introduction
Adult tissue stem cells are thought to be involved in tissue
maintenance and repair processes. When numbers are low,
tissue stem cells are replenished by mesenchymal stem cells
(MSC) via the blood system [1]. Depletion of the stem
cell population has been suggested to contribute to a large
number of degenerative diseases of brain, liver, skin, bone
and plays a role in many aging-related diseases [2]. MSC
resideinthebone marrowandcandiﬀerentiate into avariety
oftissuesincludingbone,fat,andcartilageinvitroandinvivo
[3, 4]. MSC are therefore ideal candidates for use in tissue
engineering and cell therapy. MSC are particularly attractive
because of the ease of isolation and manipulation.
It has been demonstrated that MSC ex vivo exhibit the
characteristicstypicaloftheHayﬂickmodelofcellularsenes-
cence with a limited life span and in addition telomere short-
ening, accumulation of β-galactosidase [5], and impairment
of diﬀerentiation [6]. Increased resistance to in vitro aging
and extended expansion would be desirable characteristics
for improved tissue engineering and cell therapy especially
for the elderly. Several attempts to delay in vitro aging have
been performed including reductions in oxygen level, tem-
perature, glucose [7], genetic manipulation [8], and telom-
erase overexpression [9].
Many surfaces and scaﬀolds have been extensively
evaluated for tissue engineering purposes. The eﬀect of
the mechanical stimulation of a particular surface on the
behavior of MSC has been studied for a variety of potential
diﬀerentiation eﬀects. Mechanical stimulation either by
vibrating cells, stretching cells or by providing surfaces
with diﬀerent mechanical properties can induce osteogenic
diﬀerentiation or inhibit adipogenesis [10] through durable
b-catenin activation [11].
Fibrin is a biodegradable polymer that is being increas-
ingly used in tissue engineering applications and is showing
promise as an alternative scaﬀold in vascular tissue engineer-
ing [12, 13] and skin [14]. Under physiological conditions,2 International Journal of Biomaterials
a ﬁbrin clot is formed after trauma and the ﬁbrin is respon-
sible for most of the biological and mechanical properties of
the blood clot [15]. The mechanical properties of ﬁbrin clots
are particularly important as they serve as both gap ﬁllers to
prevent bleeding and as a mechanical support to stabilise the
wound. Because of this ﬁbrin clots are remarkably extensible
and elastic. The use of ﬁbrin as a tissue engineering scaﬀold
would therefore seem highly appropriate as in many ways
the tissue engineering process could be considered to be a
reiteration of the wound healing process.
Although a role in wound healing has been suggested
for MSC, there is little direct biological evidence to support
this. It has been suggested that ﬁbrin can act as a form of
“stem cell niche” for endothelial progenitor cells [10], and it
wouldseemlogicalthatthismightalsobethecasewithMSC.
It is known that MSC can travel through the circulation
and become incorporated into transplanted tissues [16–18]
and ﬁbrin has been shown to be highly haptotactic for a
number of mesenchymal cell types including MSC [19, 20].
Research has been completed demonstrating that MSC are
able to adhere, spread, and proliferate when seeded into
a ﬁbrin gel with low thrombin to ﬁbrinogen ratios [21].
Stromal cells do not contract the ﬁbrin and the material
has no toxic eﬀect on lapine MSC [11]. In addition ﬁbrin
can be isolated from the same donor as the MSC would
therefore be a good material for clinical translation of cell
preparations as the whole procedure would be performed
using autologous material. However, there is lack of available
data looking at the eﬀects ﬁbrin has on MSC growth and
diﬀerentiation behaviour. We investigated the eﬀect of ﬁbrin
on MSC from normal and diabetes type I rats as well as MSC
from young and aged human donors. It is known that MSC
from diabetic [22] and old donors [23, 24]d oe x p a n dl e s sin
vitro and show earlier senescence. The aim was to establish
a surface minimising in vitro aging and with good growth
and diﬀerentiation potential. Growth and diﬀerentiation was
evaluated on ﬁbrin scaﬀolds with a range of stiﬀnesses to
identify the optimal concentration of ﬁbrin to support MSC.
2.MaterialsandMethods
2.1. Chemicals. All chemicals were obtained from Sigma-
Aldrich (Dorset, UK) unless otherwise stated and used
without further puriﬁcation.
2.2. Cell Culture. Dulbecco’s Modiﬁed Eagle Medium (Cam-
brex Bio Science, Workingham, UK) was supplemented
with 10% Serum Supreme (Cambrex Bio Science, Work-
ingham, UK), 1% Ultraglutamine (BioWhittaker, UK), and
1% penicillin-streptomycin solution and will hereafter be
referred to as growth medium. For osteogenic diﬀerentia-
tion cells were cultured in growth medium supplemented
with dexamethasone (10
−8 M) and ascorbate-2-phosphate
(50μg/mL).
2.3. Mesenchymal Stem Cells. Wistar rats were purchased
from Harlan (Bicester, UK) and kept on site according to
home oﬃce regulations. To induce type I diabetes rats were
injected with a single dose of streptozotocin (STZ 65mg/kg
body weight) in ice-cold 0.01M sodium citrate buﬀer (pH
4.5) at 3-month old. Rats were allowed food and water ad
libitum. Bodyweights were monitored weekly, along with
urine glucose levels. Blood glucose levels were determined at
the time of death. Rats of a similar age were used as healthy
comparisons. Bone marrow cells were obtained centrifugally
from tibiae and femurs according to the method of Dobson
et al. [25] and MSC isolated by the method of Sekiya et al.
[26].
Human MSC were purchased from Tulane University
(Emeryville, Calif, USA) or AllCell (Emeryville, Calif, USA).
MSC isolated from donors aged between 18–25 were classi-
ﬁed as young whilst MSC isolated from donors aged 55–60
were classiﬁed as old.
2.4. Immunophenotyping of Mesenchymal Stem Cells. To
conﬁrmMSCphenotype,humanMSCwereharvestedafter7
daysandstainedwithantibodiesagainstCD11,CD31,CD44,
CD45, CD90, CD105, D7ﬁb, and stro-1 (diluted 1:100; 4◦C;
30min; Serotec, Oxford, UK). Rat MSC were stained for
CD11, CD44, CD45, CD90, and CD105. Cell phenotyping
and cell size were performed using a personal ﬂow cytometry
system (GUAVA Instruments, Hayward, USA, or an Acuri
FACS).
2.5. Demonstration of Diﬀerentiation Potential of Mesenchy-
mal Stem Cells. 20,000 cells were seeded in 24-well plates
and incubated in osteogenic medium (containing 10
−8 M
dexamethasone and 50μg/mL ascorbate-2-phosphate for
14 days. MSC were ﬁxed and stained histochemically for
alkaline phosphatase activity. Brieﬂy, MSC were incubated
for30minatroomtemperatureinasolutionofnaphtholAS-
BI phosphate (0.05mg/mL) in Tris buﬀer (0.08M, pH 7.5)
containing fast red bb or fast violet (1mg/mL), washed, and
photographed. For adipogenic diﬀerentiation 20,000 cells
were seeded in 24-well plates and incubated in adipogenic
diﬀerentiation medium (1mM dexamethasone, 5mg/mL
insulin, 0.5mM isobutylmethylxanthine (IBMX), 60mM
indomethacin) for 14 days. Cells were ﬁxed with isopropanol
and stained with oil red O solution to detect the presence of
neutral lipid vacuoles and photographed.
2.6.ProductionoftheFibrinScaﬀolds. FibrinogentypeIfrom
bovine plasma was dissolved in medium at 37◦Cf o rar a n g e
of concentrations (3, 10, and 30mg/mL). The mixture was
gentlyagitateduntiltheﬁbrinogendissolvedandthencooled
by refrigeration. Thrombin from bovine plasma was added
(1unit/mL) to induce gelation. 5mL was added to each
25cm2 culture ﬂask. Flasks were incubated at 37◦Cf o r1h
and rinsed with PBS before use. The MSC were seeded on
top of the ﬁbrin scaﬀold.
2.7. Colony-Forming Unit Fibroblastic Assay. To determine
proliferation capacity and maintenance of diﬀerentiation
potential the colony-forming unit ﬁbroblast assay was
employed as a modiﬁcation of the technique originally
described by Kuznetsov et al. [27]. Primary MSC were
cultured on ﬁbrin gels (3, 10 and 30mg/mL) and tissue
cultureplastic(TCP)controlsfor7days.1000cellswerethenInternational Journal of Biomaterials 3
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Figure 1: MSC validation. MSC isolated from humans and rats were immunophenotyped using typical MSC marker (Figures 1(a) and
1(b)), and the stem cell potential was conﬁrmed by diﬀerentiating them into adipocytes and osteoblasts (Figures 1(c) and 1(d)).
transferred to 55-cm2 plates and cultured for a subsequent
14 days in osteogenic medium. At this point colonies were
ﬁxedinethanol,sequentiallystainedforalkalinephosphatase
and total colonies and photographed as previously described
[28].
2.8. Colony Analysis. Colony numbers were assessed using
the method of Dobson et al. [25]. Brieﬂy, the acquired digital
images were imported into Photoshop, colony irregularities
smoothed out and converted into a 256-level greyscale
format. The greyscale images were then imported into
Bio-image “Intelligent Quantiﬁer” and the colony number
calculated.
2.9. Data Analysis. Values were expressed as mean ± stan-
dard deviation of three experiments. Comparison of results
was performed by one-way analysis of variance (ANOVA)
and multiple comparisons made using Tukey’s test. Data was
considered signiﬁcantly diﬀerent when P<0.05.
3. Results
3.1. Clonogenic and Osteogenic Diﬀerentiation Potential of
Healthy and Diabetic Rat Mesenchymal Stem Cells after
Preculture on Fibrin. MSC were isolated from normal or
streptozotocin type I diabetic rats (2-3-month old) and
their phenotype conﬁrmed by ﬂow cytometric analysis. Cells
were CD44 and CD90 positive, CD45 low, and negative
for CD11 (Figure 1(a)). The cells were able to diﬀerentiate
into adipocytes and osteoblasts under appropriate culture
conditions (Figure 1(b) and 1(c)).
To determine the eﬀects on the clonogenicity and reten-
tion of diﬀerentiation potential of culturing MSC on three-
dimensional ﬁbrin scaﬀolds with physiologically relevant
elasticmoduli,freshlyisolatedMSCwereculturedon3,10or
30mg/mL ﬁbrin and on TCP for 7 days before transferring
1000 cells to uncoated Petri dishes and culturing for a
further 14 days in osteogenic growth medium. We found
that MSC derived from young rats showed increased CFU-
f frequencies compared to MSC derived from rats 12 weeks
after streptozotocin injection.
Frequency of ALP colonies was signiﬁcantly increasing
on ﬁbrin in comparison to TCP (Figure 2(a)) but the average
colony size was not aﬀected (Figure 2(b)) .T h es a m ew a s
observed for the frequency of total colonies (Figure2(c))a n d
the average colony size of these (Figure 2(d)). The initially
lower colony numbers from diabetic rats was not modulated
by culturing on ﬁbrin and the same trend was found with4 International Journal of Biomaterials
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Figure 2: Eﬀects of ﬁbrin surfaces on healthy and diabetic rat MSC. MSC isolated from young and diabetic rats were grown on ﬁbrin gels
for 7 days, and then 1000 cells were seeded into the CFU assays under osteogenic conditions. ALP-positive (grey) and total colony numbers
(black) were calculated for normal rat MSC (a) as well as the mean size of the colonies (b). CFU numbers for MSC from were also calculated
(c) as well as the mean colony size (d). ∗Denotes a statistically signiﬁcant diﬀerence from the other groups.
regards to the CFU size (total colony count) and the number
andsizeoftheALP-positive colonies(Figures2(b)and2(d)).
3.2. Clonogenic and Osteogenic Diﬀerentiation Potential
between Old and Young Human Mesenchymal Stem Cells.
Young MSC were isolated from 18–25-years-old donors and
old MSC from donors aged between 55 and 60 years. Cell
phenotype was conﬁrmed by ﬂow cytometric analysis. Cells
were CD44, CD90, stro-1, and D7ﬁb positive and CD11,
CD31, and CD45 low (Figure 1(d)). The cells were able
to diﬀerentiate into osteoblasts and adipocytes under the
appropriate culture conditions (Figures 1(e) and 1(f)).
The number of colonies of expanded young human MSC
was positively linked to the softness of the ﬁbrin substrate.
MSC were cultured on the diﬀerent surfaces and then
reseeded onto TCP for the CFU-f assay. The number of ALP-
positivecoloniesincreasedsigniﬁcantlyaftercultureon3and
10mg/mL ﬁbrin relative to TCP (Figure 3(a)). Total colony
numbersfollowedthesametrend;howeveronlythe3mg/mL
ﬁbrin leads to a signiﬁcant increase in colony numbers. The
size of colonies was slightly but not signiﬁcantly increased
when expanded on 10mg/mL ﬁbrin gels (Figure 3(b)).
3.3. Response of Old MSC Cultured on Fibrin. In general
the number of CFU derived from cultured MSC from old
donors is much lower compared to the MSC from young
donors (Figure 3). Interestingly, we see the opposite trend
for CFU numbers using old MSC expanded on the diﬀerent
surfacescomparedtoyoungMSC.Weﬁndsigniﬁcantlymore
colonies on TCP and less on the softer surfaces, with no
diﬀerence between ﬁbrin concentrations. The trend is not
signiﬁcant for ALP-positive colonies but for total colonies.
For MSC from aged donors we ﬁnd ∼50% ALP-positive
colonies compared to MSC from young donors. Total colony
numbers are decreased by ∼40%. If we compare this to the
ﬁbrin concentration which gave the highest CFU numbers
with the MSC from young donors we ﬁnd a much greater
decrease. On 3mg/mL ﬁbrin we only ﬁnd 5% ALP-positive
colonies and ∼10% total colonies using MSC from aged
donor. Colony sizes were also slightly larger on plastic and
the 30mg/mL ﬁbrin but did not reach signiﬁcance (Figures
3(b) and 3(d)). Also the old MSC do become smaller on
the ﬁbrin surfaces on all tested concentrations (Figures 4(c)–
4(h)). On the plastic they have an enlarged morphology
typical for senescent MSC, and on the highest concentrated
ﬁbrin gel we ﬁnd them to be much smaller and highly
aligned (Figures 4(f) and 4(h)). MSC on the other two
concentrations followed the same pattern as MSC from
young donors (data not shown).
3.4. Eﬀect of Fibrin on Expansion and Diﬀerentiation of Sec-
ondary Mesenchymal Stem Cells. To assess whether the eﬀect
of substrate stiﬀness on the clonogenic potential of MSC
was still present after an initial expansion on the 10mg/mLInternational Journal of Biomaterials 5
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Figure 3: Eﬀects of ﬁbrin surfaces on young and old human MSC. Isolated MSC from young donors and aged donors were grown on ﬁbrin
gelsfor7days,andthen1000cellswereseededintotheCFUassaysunderosteogenicconditions.ThenumberofALP-positivecolonies(grey)
and total colony numbers (black) were calculated for young (a) and aged (c) MSC. Mean sizes of colonies were calculated for young (b) and
aged (d) donor MSC. ∗Denotes a statistically signiﬁcant diﬀerence from the other groups.
ﬁbrin preparation (showing the highest CFU-f numbers),
MSC were re-seeded onto the diﬀerent ﬁbrin substrates (3–
30mg/mL)toseeifthecellsretainedtheinﬂuencebytheﬁrst
substratum. Secondary MSC followed the same trend as the
primaryMSC.Anincreaseinthenumberofcoloniesperdish
after preculture on the ﬁbrin compared to the TCP control
was observed; however this time also the 10mg/mL ﬁbrin-
cultured MSC showed a signiﬁcant diﬀerence in comparison
to TCP-cultured MSC (Figure 4(a)). However, unlike the
primary human MSC, no diﬀerence in colony size was seen
between the diﬀerent groups (Figure 4(b)).
3.5. Morphological Comparison. M S Cc u l t u r e do nﬁ b r i n
changed their morphology according to the ﬁbrin softness
(Figures 4(c)–4(h)) .T h ec e l ls i z ew a sr e d u c e do na l lﬁ b r i n
surfaces. This was conﬁrmed by analysing cell size by
ﬂow cytometry (Table 1). On the 30mg/mL ﬁbrin, and
to a lesser extent on the 10mg/mL ﬁbrin, the MSC were
highly aligned. Furthermore, on the 3mg/mL surfaces the
cells started to form networks. As this hinted towards a
potential better self-renewal we cultured these MSC for one
passage on the diﬀerent ﬁbrin concentrations and analysed
second-generation colony formation. The MSC cultured on
plastic lost about 90% of their colony-forming capacity. The
frequency of CFU could be increased by a factor of about 5
Table 1: Cell size grown on ﬁbrin. Fibrin gels were made by
mixing ﬁbrinogen (3, 10, and 30mg/mL) with thrombin (1μl/mL).
Diﬀerent MSC types were analysed for cell sizes.
Cell type Abitary units
Young rMSC 329 ±136
Diabetic rMSC 392 ±150
Young rMSC (30mg/mL) 420 ±10
Young hMSC 408 ±51
Aged hMSC 420 ±57
Aged hMSC (30mg/mL) 344 ±127
when the cells were cultured on 3mg/mL ﬁbrin; however no
eﬀect on proliferation rates was seen (Figures 4(a) and 4(b)).
3.6. Eﬀect of Fibrin Concentration on Gel Stiﬀness. One pos-
sible factor contributing to the eﬀects of ﬁbrin concentration
on MSC clonogenic capacity is its eﬀects on ﬁbrin gel
stiﬀness. To determine the eﬀect of ﬁbrin on gel stiﬀness a
stress strain plot was calculated using a Bose Electroforce
3200 (Figures 5(a)–5(c)). As no linear region was found,
the stiﬀness was measured using a tangent modulus at 20%
strain. The data showed that as the concentration of ﬁbrino-
gen increased so did the stiﬀness with a modulus of 16.7kPa6 International Journal of Biomaterials
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Figure 4: MSC morphology and self-renewal. MSC from an 18-year-old healthy donor were cultured on 10mg/mL ﬁbrin for 7 days before
re-seeding them onto diﬀerent concentrations of ﬁbrin or TCP. We call these secondary colonies. The diﬀerent surfaces were again tissue
culture plastic, 3mg/mL ﬁbrin gel, 10mg/mL, and 30mg/mL (d). MSC from a 55-year-old donor are cultured on TCP and 30mg/mL ﬁbrin
gel. Colony numbers (a) as well as size (b) are shown and the diﬀerent morphologies (c–h) are shown. ∗Denotes a statistically signiﬁcant
diﬀerence from the other groups.
for 3mg/mL, 40.4kPa for 10mg/mL, and 77kPamg/mL for
30mg/mL. The stiﬀness of the 30mg/mL gel was statistically
diﬀerence from the 3 and 10mg/mL gel (Figure 5(d)).
4. Discussion
MSC are becoming increasingly popular for tissue engineer-
ing and cell-based therapies due to the ease of isolation and
cultivation. Their immunomodulatory functions as well as
their secretome make them an ideal source for therapies.
However in vitro expansion is needed to expand numbers,
as MSC occur in low numbers (1 of 100,000 cells) in
bone marrow [29] and decline in frequency with age [24].
Expansion leads to in vitro aging of the MSC accompanied
with a declining proliferation and diﬀerentiation potential
[30]. Aged MSC express markers typical of aged somatic
cells including increased p53 and p21 levels [31], have
a changed morphology [3], and express the senescence
marker β-galactosidase [23]. Clinical use of aged MSC could
lead to serious side eﬀects as it is known that senescent
cells can induce cancer formation [32]. Human adipose-
tissue-derived mesenchymal stem cells can spontaneously
transform when they reach senescence [33]. Because of
this, it is necessary to keep the numbers of senescent cells
present in tissue-engineered constructs as low as possible
and to minimize senescence during expansion. It is now well
acknowledgedthatstemcellsinteractwiththeirenvironment
[34]. Manipulation of stem cell behaviour by changing the
niche of the stem cells is possible. Extracellular matrix
components are part of the stem cells niche. Fibrin is a
natural biodegradable polymer increasingly used in tissue
engineering and can be produced autologously and is
therefore a good choice of scaﬀold for potential therapeutic
applications. It is widely used in cartilage tissue engineeringInternational Journal of Biomaterials 7
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Figure 5: Tangent modulus of a range of ﬁbrin gel produced with varying ﬁbrinogen concentrations. Fibrin gels were made by mixing
ﬁbrinogen (3, 10, and 30mg/mL) with thrombin (1μl/mL). Tensile testing of the gels was performed using a Bose ElectroForce 3200 (a–c).
The tangent moduli were calculated from the slope of the plot of stress versus strain at 20% strain (n = 6) (d).
[35] and can be rapidly degraded by plasmin. It is therefore
an ideal candidate for in vitro expansion of MSC and could
also be used for transplantation to protect and modulate
MSC behaviour.
Fibrin gels with various ﬁbrinogen concentrations were
made with diﬀerent mechanical properties (diﬀerent Young’s
moduli). MSC were seeded onto these gels and cultured
before being analysed. We found that MSC from young rats
andMSCfromyounghumansrespondedtothediﬀerentﬁb-
rinogen concentrations. The highest self-renewal measured
usingtheCFU-fassaycapacitywasfoundonthesoftestﬁbrin
surfaces. This eﬀect however was lost for MSC from either
diabetic Type I rats or aged human donors. We know from
former studies that CFU-f numbers from diabetic rats and
aged humans [24] were lower compared to young healthy
controls. This is now conﬁrmed for the frequency of culture-
expanded MSC with the same trends observed. The use of
the CFU-f as an assay to determine the number of MSC
present in a cell preparation has been well characterised [25],
with the assumption that each colony arises from a single cell
allowing for the number of colonies to be correlated to the
number of stem cells in the original sample. Fibrin gels seem
to alter the frequency of stem cells in the MSC cultures and
can increase in young MSC the number of MSC with an high
proliferative and diﬀerentiation potential. MSC cultured on
ﬁbrin appeared to align along the same axis whereas on TCP
they had a typical “cobble-stone-” like appearance. Not only
were diﬀerences seen in the morphology of the cells but also
the size of the cell was diﬀerent. It is well accepted that
an increase in cell size is linked to senescence of the cell
and thereby suggests that smaller cells are “younger” than
the larger ones [23]. The MSC from old donors decreased
in size after culturing on the soft ﬁbrin surface, maybe
due to matrix-induced rejuvenation eﬀects. In ﬁbroblasts8 International Journal of Biomaterials
the senescence phenotype could be reversed by altering cell
attachment via the inhibition of calveolin-1 [36].
It was observed that not only CFU-f eﬃciency, but also
the number of colonies that stained positive for ALP was
higher after pre-culture on the softer substrates for cells from
young and nondiseased donors. This data suggests that pre-
culturing on the softer substrates maintains a more “stem-
cell-” like phenotype. A study investigating maintenance
of human MSC phenotype has implicated the basement
membrane ECM as a critical factor in the proliferative
life span and maintenance of diﬀerential potential of stem
cells in culture and highlights the importance of a native,
soft substratum for maintaining a more “stem cell-” like
phenotype and showed greater eﬀects than growth factors
like ﬁbroblastic growth factor [37]. Studies on the eﬀect of
temperature on MSC from old donors showed the same
reduced response to an environmental challenge [38]. Pro-
teomicstudiesonhumanagedMSCshowedthatantioxidant
andcytoskeletonfunctionsarediminishedinagedMSC[39].
Thebeneﬁcialeﬀectsofsurfacesonthe“stemness”properties
could be mediated via the cytoskeleton, or due to changes
in the signal transduction pathway. Cell shape was shown
to regulate stem cell diﬀerentiation [40]. The Rho family
of small GTPases transmit signals from the extracellular
matrix to the actin skeleton and the nucleus, modulating
gene expression [36, 41]. Receptors involved in the signal
transmission are integrins, dystroglycans, syndecans, CD44,
and Rhamm. Such signals can lead to dramatic changes in
cell morphology and cell architecture involving cytoskeleton
and chromatin structures, aﬀecting gene expression [42].
Lamins making up the nuclear envelope are connected to
the actin ﬁlaments through nespin, anchoring the nucleus to
the cytoskeleton. Disruption of actin leads to global histone
deacetylation and cells rounding up [43].
Outlook. This is the ﬁrst report of the self-renewal potential
of expanded MSC from aged and diseased donors on ﬁbrin
scaﬀolds. We have shown that young MSC maintain a better
self-renewal on soft ﬁbrin gel, but this beneﬁt is partly
lost when cells from aged or diabetic organisms are used.
Additional modiﬁcations of the scaﬀolds might be necessary
to gain the same eﬀects seen in young MSC.
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